News of the layoffs come just one day after the company reported a 5% year over year revenue increase — boosting revenue to ...

It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their US ...

AbbVie ( ABBV 0.64%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...

January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

Of the 102 company launches or series A financings since October 2023, just nine had a woman at the helm, according to a ...

With the Canadian economy experiencing a contraction in November and a recent interest rate cut by the Bank of Canada due to tariff uncertainties, investors are navigating a complex landscape. In such ...

The BioSecure Act seeks to reduce US-China biotech ties, creating potential for India to become a biomanufacturing hub.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Let us look at some biotech stocks, AMGN, CRSP, MRNA, SRPT and VRTX, which are poised to beat on fourth-quarter earnings.

Aurion Biotech, Inc. plans $100M IPO for corneal disease treatments, limited competition, Phase 1/2 trials underway with ...

Some 4,000 biotech industry businesses employ about 40,000 workers at well-above-average wages, with ripple effects across ...

A Huntsville-based biotechnology company has secured $10 million in funding to begin the trial of a new way to deliver medication to advanced Parkinson’s disease patients.